Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A retinitis pigmentosa that has material basis in variation in the chromosome region 6q23.
Features include: Nyctalopia, Optic disc pallor, Rod-cone dystrophy, and Blurred vision.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 2 | Optic disc pallor, Blurred vision |
Biomarker and diagnostic research for retinitis pigmentosa 63 has been reported in the published literature.
No clinical trials have been registered for retinitis pigmentosa 63.
27 publications have been identified in PubMed for retinitis pigmentosa 63. Research spans Epidemiology / Natural History (40%), Basic Science / Preclinical (16%), and Gene Therapy / Novel Therapeutics (16%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 10 | 40% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Laboratory research
4 |
16% |
New treatment approaches | 4 | 16% |
Testing and diagnosis research | 3 | 12% |
Clinical study results | 2 | 8% |
Research summaries | 1 | 4% |
Patient case studies | 1 | 4% |
Jony MJ (2026). [PMID: 41944104](https://pubmed.ncbi.nlm.nih.gov/41944104/). *Curr Drug Deliv*. [Gene Therapy / Novel Therapeutics]
Beaulieu C (2026). [PMID: 41954904](https://pubmed.ncbi.nlm.nih.gov/41954904/). *JAMA Ophthalmol*. [Epidemiology / Natural History]
He Y (2026). [PMID: 41507979](https://pubmed.ncbi.nlm.nih.gov/41507979/). *J Transl Med*. [Gene Therapy / Novel Therapeutics]
Charng J (2026). [PMID: 41552664](https://pubmed.ncbi.nlm.nih.gov/41552664/). *Ophthalmol Sci*. [Basic Science / Preclinical]
Ulusoy Tangul S (2025). [PMID: 39412385](https://pubmed.ncbi.nlm.nih.gov/39412385/). *Fetal Pediatr Pathol*. [Case Report / Case Series]
Hoy SM (2025). [PMID: 40540142](https://pubmed.ncbi.nlm.nih.gov/40540142/). *Mol Diagn Ther*. [Review / Meta-Analysis]
Liang J (2025). [PMID: 41286208](https://pubmed.ncbi.nlm.nih.gov/41286208/). *Mol Neurobiol*. [Basic Science / Preclinical]
Kong X (2025). [PMID: 41282901](https://pubmed.ncbi.nlm.nih.gov/41282901/). *medRxiv*. [Clinical Trial Publication]
Kominami T (2025). [PMID: 39937339](https://pubmed.ncbi.nlm.nih.gov/39937339/). *Jpn J Ophthalmol*. [Epidemiology / Natural History]
Britten-Jones AC (2025). [PMID: 39811267](https://pubmed.ncbi.nlm.nih.gov/39811267/). *Ophthalmol Sci*. [Epidemiology / Natural History]